Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Adaptive, Randomised, Multidomain, Platform Trial for Dose Optimization in the Treatment of Adult Patients With Haematological Diseases (BLOOD-dose): Core Protocol

NCT07474961 is registered in ClinicalTrials.gov with Anne Louise Tølbøll Sørensen as lead sponsor.

NCT NCT07474961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07474961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Adaptive, Randomised, Multidomain, Platform Trial for Dose Optimization in the Treatment of Adult Patients With Haematological Diseases (BLOOD-dose): Core Protocol
Lead sponsor
Anne Louise Tølbøll Sørensen
Phase
Phase 4
Overall status
Not yet recruiting
Start date
March 31, 2027
Completion date
December 31, 2036
Enrollment
400 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma, waldenstrom macroglobulinaemia